The Regulatory Review Process in South Africa: Challenges and Opportunities for a New Improved System.
Andrea KeyterJoey GouwsSam S SalekStuart WalkerPublished in: Therapeutic innovation & regulatory science (2018)
As the MCC transitions to the newly established South Africa Health Products Regulatory Authority, it would be crucial for the authority to recognize the opportunities for an enhanced regulatory review and should consider models such as abridged assessment, which encompass elements of risk stratification and reliance. It is hoped that resource constraints may then be alleviated and capacity developed to meet target timelines.